Answers are grounded in this paper and cite their sources.
The HDT and SDT regimens used in S9321 yielded comparable response rates and PFS and OS durations. IFN maintenance therapy did not benefit patients who achieved > or = 75% tumor reduction on either arm.
No takes yet. Share an insight, caveat, or question.
Barlogie et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: